Pier Capital LLC Raises Holdings in Quanterix Co. (NASDAQ:QTRX)

Pier Capital LLC boosted its stake in Quanterix Co. (NASDAQ:QTRX) by 32.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 679,680 shares of the company’s stock after buying an additional 167,882 shares during the quarter. Pier Capital LLC owned approximately 1.76% of Quanterix worth $7,225,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of the stock. EntryPoint Capital LLC raised its holdings in shares of Quanterix by 117.8% in the fourth quarter. EntryPoint Capital LLC now owns 35,504 shares of the company’s stock worth $377,000 after acquiring an additional 19,203 shares during the last quarter. Vanguard Group Inc. raised its stake in Quanterix by 0.9% in the 4th quarter. Vanguard Group Inc. now owns 2,217,225 shares of the company’s stock valued at $23,569,000 after purchasing an additional 19,386 shares during the last quarter. Fox Run Management L.L.C. lifted its holdings in Quanterix by 258.7% in the 4th quarter. Fox Run Management L.L.C. now owns 43,784 shares of the company’s stock valued at $465,000 after purchasing an additional 31,577 shares in the last quarter. KLP Kapitalforvaltning AS acquired a new stake in shares of Quanterix during the 4th quarter worth about $66,000. Finally, American Century Companies Inc. boosted its stake in shares of Quanterix by 9.1% during the 4th quarter. American Century Companies Inc. now owns 71,992 shares of the company’s stock worth $765,000 after purchasing an additional 6,023 shares during the last quarter. Institutional investors and hedge funds own 86.48% of the company’s stock.

Quanterix Stock Down 0.4 %

Shares of NASDAQ:QTRX opened at $7.19 on Tuesday. The company has a market cap of $278.80 million, a P/E ratio of -6.78 and a beta of 1.33. The business has a fifty day simple moving average of $8.15 and a 200-day simple moving average of $10.78. Quanterix Co. has a 52 week low of $6.30 and a 52 week high of $24.05.

Quanterix (NASDAQ:QTRX) last posted its quarterly earnings results on Monday, March 17th. The company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.03). The business had revenue of $35.16 million during the quarter, compared to analysts’ expectations of $34.93 million. Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.74%. Sell-side analysts expect that Quanterix Co. will post -0.98 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group cut their price objective on shares of Quanterix from $20.00 to $15.00 and set a “buy” rating for the company in a research report on Tuesday, March 18th.

Quanterix Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.